Pharmx Technologies Limited (ASX:PHX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0820
-0.0040 (-4.65%)
Sep 9, 2026, 2:53 PM AEST

Pharmx Technologies Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
7.627.627.326.496.135.39
Revenue Growth
2.42%4.06%12.84%5.88%13.78%-54.65%
Gross Profit
1.981.981.922.362.012.14
Operating Income
-1.76-1.76-0.1-1.36-0.670.13
Net Income
-1.83-1.83-0.26-1.77-1.050.25
Earnings Per Share
-0.00-0.00-0.00-0.00-0.000.00
EPS Growth
------78.89%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
2.572.574.1713.1412.815.76
Total Debt
0.540.540.890.240.030.33
Net Cash (Debt)
2.032.033.2812.912.775.43
Net Cash Growth
-18.53%-38.04%-74.58%0.95%135.12%-11.76%
Net Cash Per Share
0.000.000.010.020.020.01

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
0.830.83-8.133.2110.943.28
Capital Expenditures
-0.02-0.02-0.03-0.02-0.09-0.1
Free Cash Flow
0.810.81-8.163.1910.863.19
Free Cash Flow Growth
-17.69%---70.63%240.94%11.29%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
25.99%25.99%26.17%36.33%32.72%39.74%
Operating Margin
-23.15%-23.15%-1.37%-21.01%-10.85%2.36%
Pretax Margin
-22.15%-22.15%1.08%3.10%-11.73%2.27%
Profit Margin
-23.97%-23.97%-3.61%-27.27%-17.15%4.68%
FCF Margin
10.57%10.57%-111.49%49.16%177.23%59.15%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
-----80.52
Forward PE
-21.2521.2521.2521.2521.25
P/FCF Ratio
67.85106.50-7.132.046.37
PS Ratio
7.1711.267.603.513.613.77